跳至主要内容
临床试验/ISRCTN12839803
ISRCTN12839803终止未知

Randomised factorial design controlled trial comparing carbamazepine, levetiracetam or active monitoring combined with or without sleep behaviour intervention in treatment naive children with rolandic epilepsy

King's College London0 个研究点目标入组 330 人开始时间: 2019年5月15日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children diagnosed with RE
  • 2. EEG showing focal sharp waves with normal background
  • 3. Aged >=5 years and <13 years at the time of randomisation
  • 4. Currently untreated with antiepileptic drugs
  • 5. Written informed consent received from person with parental responsibility/legal representative.
  • 6. Family have a valid email address and regular internet access (for online sleep intervention)
  • 7. Parent and child are to have a good understanding of the English language.
  • Parent-child dyads meeting the trial criteria and the following characteristics will be eligible for inclusion in the qualitative sub-study:
  • 1 Ability of parent and child to speak conversational English
  • 2 Additional consent to main trial: Consent of parent to participate and for their child to participate

排除标准

  • 1. Known contraindication to any of the trial drugs
  • 2. Previously treated for epilepsy with antiepileptic drugs

研究者

相似试验